Annual report pursuant to Section 13 and 15(d)

Share-Based Compensation - Summary of Activities Under Share-Based Compensation Plans (Detail)

v3.24.0.1
Share-Based Compensation - Summary of Activities Under Share-Based Compensation Plans (Detail) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding and nonvested as of December 31, 2020, Number of Shares [1] 4,538,000  
Granted, Number of Shares [2] 3,794,000  
Vested, Number of Shares [3] (1,463,000)  
Forfeited, Number of Shares [3] (751,000)  
Outstanding and nonvested as of December 31, 2021, Shares [1] 6,118,000 4,538,000
Number of Shares, Expected to vest as of December 31, 2021 5,666,000  
Outstanding and nonvested as of December 31, 2020, Weighted Average Grant Date Fair Value Per Share [1] $ 33.14  
Granted, Weighted Average Grant Date Fair Value Per Share [2] 13.81  
Vested, Weighted Average Grant Date Fair Value Per Share [3] 35.78  
Forfeited, Weighted Average Grant Date Fair Value Per Share [3] 31.15  
Outstanding and nonvested as of December 31, 2021, Weighted Average Grant Date Fair Value Per Share [1] 20.76 $ 33.14
Expected to vest as of December 31, 2020, Weighted Average Grant Date Fair Value Per Share $ 19.94  
SARs [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Awards Outstanding, Beginning Balance [4] 3,074,000  
Granted, Number of Awards 1,814,000  
Exercised, Number of Awards (25,000)  
Forfeited, Number of Awards [5] (523,000)  
Number of Awards Outstanding, Ending Balance [4] 4,340,000 3,074,000
Number of Awards Exercisable, Ending Balance [6] 1,743,000  
Number of Awards Vested and expected to vest, Ending Balance [6] 4,298,000  
Weighted Average Exercise Price Per Award Outstanding, Beginning Balance [4] $ 24.21  
Granted, Weighted Average Exercise Price Per Award 15.92  
Exercised, Weighted Average Exercise Price Per Award 15.22  
Forfeited, Weighted Average Exercise Price Per Award [5] 32.02  
Weighted Average Exercise Price Per Award Outstanding, Ending Balance [4] 19.85 $ 24.21
Exercisable, Weighted Average Exercise Price Per Award, Ending Balance [6] 26.38  
Weighted Average Exercise Price Per Award, Vested and expected to vest, Ending Balance [6] $ 19.9  
Weighted Average Remaining Contractual Term Outstanding [4] 6 years 4 months 24 days 4 years 7 months 6 days
Exercisable Weighted Average Remaining Contractual Term [6] 2 years 2 months 12 days  
Weighted Average Remaining Contractual Term, Vested and expected to vest [6] 6 years 4 months 24 days  
Aggregate Intrinsic Value Outstanding [4],[7] $ 2.4 $ 0.3
Exercisable, Aggregate Intrinsic Value [6],[7] 0.0  
Aggregate Intrinsic Value, Vested and expected to vest [6],[7] $ 2.4  
Granted, Weighted Average Grant Date Fair Value Per Share $ 7.83 $ 6.38
[1] Includes 307,116 and 520,138 performance based stock unit awards as of December 31, 2023 and 2022, respectively, which represents the maximum amount that can vest.
[2] Includes 29,927 performance-based stock unit awards.
[3] Includes 183,095 performance-based stock unit awards.
[4] Includes 0.6 million and 0.8 million performance condition SARs as of December 31, 2023 and 2022, respectively.
[5] Includes 0.2 million performance condition SARs.
[6] Includes 0.6 million performance condition SARs.
[7] The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards.